Our Our Way to a Vaccine - Part 2
Today's blog is a follow-up to last week's first part blog about "On Our Way to a Vaccine, which is based upon an excellent article in the New York Times Sunday Magazine. [ Entitled: "The Development of a Vaccine for COVID-19," June 14, 2020, Page 36-43, 56. ] So, from where we left off last week - - - Dan Barouch says, "That still leaves the question as to how to get that [aforementioned ] gene into human cells." (1) He suggests that one way to do this is a vector-based vaccine. "A vector-based vaccine uses a delivery vehicle --- one example would be a combined adenovirus, or a "harmless virus" carrier, like a common cold --- to deliver the protein into a person's cells." George Yancopoulos says, "This gene-based approach was used in the case of Ebola. (2) " But Siddhartha Mukherjee further says, "There is also the idea of further ditching "harmless virus" carrier (sic) altogether and just using ...